ACOX1

Across TCGA pan-cancer cohorts, ACOX1 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ACOX1 data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ACOX1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ACOX1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCEC show a favorable association.

COAD, SKCM, and PRAD are the cancer types where ACOX1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.089	0.781	<.001	18	view →
SKCM	DFS	Median	All	0.637	0.195	.008	7	view →
PRAD	DFS	Median	All	0.617	0.886	.029	6	view →
UCEC	DFS	Median	All	0.952	0.629	.034	6	view →
BLCA	OS	Median	III,IV	0.228	0.583	.008	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ACOX1–COAD (OS)

Open the COAD breakdown →